The Europe ureteral stent market is estimated at USD 154.8 million in 2025 and is projected to reach USD 254.2 million by 2035, growing at a CAGR of 5.08%, supported by a strong healthcare system, ...
Significantly lower TLF rates (2.8% versus 7.8%, p=0.020) with DynamX® compared to Resolute Onyx DES with no new events in bioadaptor arm between 3 and 4 years 88% reduction in Cardiovascular Death (0 ...
Reflow Medical announced the first six-month clinical results from a study of its Spur Elute sirolimus-eluting retrievable ...
Elixir Medical announced four-year results from a study comparing its DynamX coronary bioadaptor system to a leading ...
Every year, around 40,000 babies in the U.S. are born with congenital heart defects, often requiring stents to keep their blood vessels open, NBC News reported Oct. 17. Traditionally, pediatric ...
AI-assisted OCT support increased clinician confidence during PCI and reduced differences between experienced and novice OCT ...
A new report published Tuesday found over one in five coronary stents placed between 2019 and 2021 were unnecessary, costing Medicare $800 million a year and putting patients at risk of complications ...
Artivion, Inc. announced that it has completed the acquisition of its long-standing partner Endospan Ltd. On May 8, Artivion announ ...
Stents are permanent mesh tubes that help direct blood flow to the heart or other organs. Usually, stents are not replaced but may be reinforced. However, some people may experience issues such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results